ReviewFrontiers in pharmacology2026

Ceramides and neuroinflammation as immunometabolic drivers and biomarkers of major depressive disorder, treatment-resistant depression, and suicidal vulnerability.

Martin G Garcia-Juarez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.